Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 27.3647.7027.698.479.60

What is the latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS is 27.36 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202527.36
Mar202447.70
Mar202327.69
Mar20228.47
Mar20219.60

How is EV/EBIT of GLENMARK PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 27.36
-42.64
Mar2024 47.7
72.26
Mar2023 27.69
226.92
Mar2022 8.47
-11.77
Mar2021 9.6 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/EBIT ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹64,405.1 Cr 0.5% 6.4% 27.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹464,331.0 Cr 1.2% 8.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹181,466.0 Cr -0.2% 3% -0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹165,952.0 Cr 1.7% 9.9% 46.8% Stock Analytics
CIPLA ₹116,229.0 Cr -2.2% 4.5% -4.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,959.0 Cr -9% -2.1% -1.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.5%

6.4%

27.1%

SENSEX

-0.3%

4.9%

-7%


You may also like the below Video Courses